191 related articles for article (PubMed ID: 12378824)
21. TNF-alpha infusion impairs corpora cavernosa reactivity.
Carneiro FS; Zemse S; Giachini FR; Carneiro ZN; Lima VV; Webb RC; Tostes RC
J Sex Med; 2009 Mar; 6 Suppl 3(Suppl 3):311-9. PubMed ID: 19267854
[TBL] [Abstract][Full Text] [Related]
22. The role of nitric oxide in penile erection.
Cartledge J; Minhas S; Eardley I
Expert Opin Pharmacother; 2001 Jan; 2(1):95-107. PubMed ID: 11336572
[TBL] [Abstract][Full Text] [Related]
23. Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel.
Werner ME; Zvara P; Meredith AL; Aldrich RW; Nelson MT
J Physiol; 2005 Sep; 567(Pt 2):545-56. PubMed ID: 16020453
[TBL] [Abstract][Full Text] [Related]
24. Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide.
Ushiyama M; Morita T; Kuramochi T; Yagi S; Katayama S
Hypertens Res; 2004 Apr; 27(4):253-61. PubMed ID: 15127883
[TBL] [Abstract][Full Text] [Related]
25. [Effects of RhoA/Rho-kinase in the regulation of penile erection].
Xia C; Jiang R
Zhonghua Nan Ke Xue; 2007 Jun; 13(6):546-9. PubMed ID: 17615983
[TBL] [Abstract][Full Text] [Related]
26. Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.
Archer SL; Gragasin FS; Webster L; Bochinski D; Michelakis ED
Drugs Aging; 2005; 22(10):823-44. PubMed ID: 16245957
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for erectile dysfunction.
Kendirci M; Gur S; Sikka SC
Front Biosci; 2005 Sep; 10():2758-69. PubMed ID: 15970531
[TBL] [Abstract][Full Text] [Related]
28. Erectile Dysfunction in Wistar Audiogenic Rats Is Associated With Increased Cavernosal Contraction and Decreased Neuronal Nitric Oxide Synthase Protein Expression.
Rodrigues FL; Fais RS; Pereira MGAG; Garcia-Cairasco N; Tostes RC; Carneiro FS
Urology; 2017 Aug; 106():237.e1-237.e8. PubMed ID: 28483592
[TBL] [Abstract][Full Text] [Related]
29. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection.
Trigo-Rocha F; Hsu GL; Donatucci CF; Lue TF
J Urol; 1993 Apr; 149(4):872-7. PubMed ID: 8384275
[TBL] [Abstract][Full Text] [Related]
30. Constitutive LH receptor activity impairs NO-mediated penile smooth muscle relaxation.
Hiremath DS; Priviero FBM; Webb RC; Ko C; Narayan P
Reproduction; 2021 Jan; 161(1):31-41. PubMed ID: 33112284
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase type 5 regulation in the penile corpora cavernosa.
Lin CS
J Sex Med; 2009 Mar; 6 Suppl 3():203-9. PubMed ID: 19267844
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
[TBL] [Abstract][Full Text] [Related]
33. Poly(ADP-ribose) polymerase inhibition improves erectile function by activation of nitric oxide/cyclic guanosine monophosphate pathway in diabetic rats.
Li WJ; Peng Y; Zhou J; Li B; Wang H; Zhang J; Wang Z
J Sex Med; 2012 May; 9(5):1319-27. PubMed ID: 22429732
[TBL] [Abstract][Full Text] [Related]
34. Erectile hydraulics: maximizing inflow while minimizing outflow.
Meldrum DR; Burnett AL; Dorey G; Esposito K; Ignarro LJ
J Sex Med; 2014 May; 11(5):1208-20. PubMed ID: 24521101
[TBL] [Abstract][Full Text] [Related]
35. New approaches to the design and discovery of therapies to prevent erectile dysfunction.
Toque HA; Caldwell RW
Expert Opin Drug Discov; 2014 Dec; 9(12):1447-69. PubMed ID: 25195695
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat.
Bivalacqua TJ; Champion HC; Mehta YS; Abdel-Mageed AB; Sikka SC; Ignarro LJ; Kadowitz PJ; Hellstrom WJ
Int J Impot Res; 2000 Sep; 12 Suppl 3():S8-17. PubMed ID: 11002394
[TBL] [Abstract][Full Text] [Related]
37. Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction.
Lasker GF; Pankey EA; Kadowitz PJ
Physiology (Bethesda); 2013 Jul; 28(4):262-9. PubMed ID: 23817801
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-1 restores erectile function in aged rats: modulation the integrity of smooth muscle and nitric oxide-cyclic guanosine monophosphate signaling activity.
Pu XY; Wang XH; Gao WC; Yang ZH; Li SL; Wang HP; Wu YL
J Sex Med; 2008 Jun; 5(6):1345-54. PubMed ID: 18355170
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
Corbin JD
Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
[TBL] [Abstract][Full Text] [Related]
40. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats.
Hsieh GC; O'Neill AB; Moreland RB; Sullivan JP; Brioni JD
Eur J Pharmacol; 2003 Jan; 458(1-2):183-9. PubMed ID: 12498924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
